Bladder cancer
How the VA looks at Bladder cancer
VA rating schedule, diagnostic code 7528
Bladder cancer is a cancer of the genitourinary system (the organs that make and carry urine). When the VA decides a claim, it first looks at whether the cancer is connected to your military service. If it agrees there is a service connection, it then assigns a disability rating using the VA's rating schedule. Bladder cancer is rated under 38 CFR 4.115b, Diagnostic Code 7528, "Malignant neoplasms of the genitourinary system."
Under Diagnostic Code 7528, the rules assign a 100% rating while the cancer is active or while you are getting treatment such as surgery, radiation, or anti-cancer (antineoplastic) chemotherapy. That 100% rating continues for six months after treatment stops. At the end of those six months, a VA examination is required. If there has been no return of the cancer (recurrence) and no spread (metastasis), the rules say the condition is then rated on its leftover effects ("residuals") — either voiding dysfunction (problems with urine leakage, frequency, or obstructed voiding) or renal (kidney) dysfunction, whichever is the main problem. For voiding dysfunction, continual urine leakage that requires wearing absorbent materials changed more than 4 times per day can warrant up to a 60% rating. If the cancer comes back, the rules provide for the 100% rating again.
There is also a presumptive pathway that can ease the burden of proving a connection to service. A presumptive condition means the VA assumes service connection if you meet the exposure and service requirements, so you generally do not need a separate "nexus" opinion linking the cancer to service. Effective January 1, 2021, the National Defense Authorization Act for Fiscal Year 2021 added bladder cancer (along with hypothyroidism and Parkinsonism) to the list of conditions presumptively linked to Agent Orange and other herbicides. The PACT Act further expanded presumptive conditions and added more presumptive-exposure locations for Agent Orange, burn pits, and other toxic exposures. The VA decides eligibility based on the facts of each veteran's case.
If a claim is denied, that is a starting point, not the end — the VA system includes ways to seek further review. This is general educational information about how the VA's rules work, and it is not legal advice or a VA decision.
Sources
- 38 CFR 4.115b - Ratings of the genitourinary system - diagnoses (Diagnostic Code 7528, malignant neoplasms of the genitourinary system) — 38 CFR 4.115b, Diagnostic Code 7528 (opens in a new tab)
- Schedule for Rating Disabilities; The Genitourinary Diseases and Conditions — 84 FR (Federal Register), Genitourinary rating rule (DC 7528 unchanged) (opens in a new tab)
- VA adds three new Agent Orange presumptions (bladder cancer, hypothyroidism, Parkinsonism) - VA Public Health — VA Public Health - FY21 NDAA Agent Orange presumptions (opens in a new tab)
- Agent Orange exposure and disability compensation - Veterans Affairs — VA.gov - Agent Orange presumptive conditions and exposure (opens in a new tab)
- The PACT Act and your VA benefits - Veterans Affairs — VA.gov - PACT Act presumptive conditions (opens in a new tab)
Rating background drawn from federal regulations and VA guidance. Recorded source review June 2026. Educational information, not legal advice or a VA determination.
Across 2,885 Board decisions mentioning Bladder cancer
30% were granted or partly granted.
A denial is often not the end either — remands (shown below) are sent back for more development and can still end in a grant. These are whole-decision outcomes, not condition-specific success rates or a prediction of your case.
- Granted 28%
- Partly granted 3%
- Remanded 33%
- Denied 28%
- Dismissed 8%
An accredited representative can help review your notice and evidence. Find free (VSO) or accredited help →
Theories recorded in granted decisions
These are decision-level labels in granted or partly granted decisions mentioning Bladder cancer. They do not establish which theory succeeded for this condition.
- Presumptive (no nexus needed)416
- Direct service connection307
- Secondary to another service-connected condition48
Checking a rating
Ratings from individual decisions are not shown until verified against the original source. This does not mean that no rating was assigned. Check the original Board decision.
Explore the original decisions
A decision may address several conditions. Its overall outcome or exposure tags do not establish what happened to each individual claim. Verify the specific issue against the original Board decision.
Browse decisions mentioning Bladder cancer →Browse Bladder cancer decisions by year
Jump to the decisions from a specific year.
- 2026 (136)
- 2025 (257)
- 2024 (261)
- 2023 (156)
- 2022 (224)
- 2021 (189)
- 2020 (300)
- 2019 (344)
- 2018 (231)
- 2017 (97)
- 2016 (63)
- 2015 (70)
- 2014 (57)
- 2013 (49)
- 2012 (40)
- 2011 (50)
- 2010 (51)
- 2009 (59)
- 2008 (50)
- 2007 (54)
- 2006 (34)
- 2005 (35)
- 2004 (19)
- 2003 (15)
- 2002 (13)
- 2001 (10)
- 2000 (21)
Coverage is incomplete and may lag publication. A year that looks thin or missing here (especially 2011–2017) is a gap in our library, not in the Board’s decisions.
What you can do next
Related conditions
Veterans appealing Bladder cancer often look at outcomes for these too:
Get new Bladder cancer decisions by email
We’ll send the free starter guide now, then a note when notable new Bladder cancer Board decisions are added. No spam, unsubscribe any time.
We will only use this to send the guide and occasional updates for this condition. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.